PDCD6IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.399000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.512400E-01
Normal-vs-Stage2
3.902600E-01
Normal-vs-Stage3
3.473900E-02
Normal-vs-Stage4
8.270000E-01
Stage1-vs-Stage2
5.562400E-01
Stage1-vs-Stage3
1.913170E-01
Stage1-vs-Stage4
2.910200E-01
Stage2-vs-Stage3
3.254100E-02
Stage2-vs-Stage4
1.397980E-01
Stage3-vs-Stage4
9.133800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.996600E-01
Normal-vs-AfricanAmerican
5.862800E-01
Normal-vs-Asian
5.840400E-01
Caucasian-vs-AfricanAmerican
7.873400E-01
Caucasian-vs-Asian
7.629000E-01
AfricanAmerican-vs-Asian
9.822000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.068800E-01
Normal-vs-Female
3.889400E-01
Male-vs-Female
6.210800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.026800E-01
Normal-vs-Age(41-60Yrs)
5.688800E-01
Normal-vs-Age(61-80Yrs)
2.549200E-01
Normal-vs-Age(81-100Yrs)
1.738020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.596200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.615400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.977600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.146500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.731750E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.713000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.310200E-01
Normal-vs-Daily Drinker
2.185200E-01
Normal-vs-Weekly Drinker
3.036800E-01
Normal-vs-Occasional Drinker
6.154400E-01
Normal-vs-Social Drinker
2.887000E-01
Non Drinker-vs-Daily Drinker
3.548800E-01
Non Drinker-vs-Weekly Drinker
6.925200E-01
Non Drinker-vs-Occasional Drinker
4.395400E-01
Non Drinker-vs-Social Drinker
9.187800E-01
Daily Drinker-vs-Weekly Drinker
6.794000E-01
Daily Drinker-vs-Occasional Drinker
1.021630E-01
Daily Drinker-vs-Social Drinker
4.369600E-01
Weekly Drinker-vs-Occasional Drinker
2.672600E-01
Weekly Drinker-vs-Social Drinker
7.537600E-01
Occasional Drinker-vs-Social Drinker
3.656400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.876960E-01
Normal-vs-Grade 2
3.017900E-02
Normal-vs-Grade 3
1.984260E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.519400E-03
Grade 1-vs-Grade 3
3.860200E-03
Grade 1-vs-Grade 4
1.876960E-01
Grade 2-vs-Grade 3
4.472400E-01
Grade 2-vs-Grade 4
3.017900E-02
Grade 3-vs-Grade 4
1.984260E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.040400E-01
Normal-vs-NonDiabetic
2.519800E-01
Diabetic-vs-NonDiabetic
7.475200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.217400E-01
Normal-vs-NoPancreatitis
2.847200E-01
Pancreatitis-vs-NoPancreatitis
9.403200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.402800E-01
Normal-vs-N1
3.785800E-01
N0-vs-N1
6.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.186200E-01
Normal-vs-TP53-NonMutant
2.106800E-01
TP53-Mutant-vs-TP53-NonMutant
2.643900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
